Jaguar Health, Inc. (NASDAQ:JAGX)

PRESS RELEASE

published on 12/06/2023 at 14:30, 2 years 2 months ago

Study Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) Website
Napo Pharmaceuticals and Advocates for Collaborative Education (ACE) have released the abstract for a quality of life survey for individuals with a cancer diagnosis, shedding light on the challenges faced. The survey findings will be presented at the December 2023 SABCS, focusing on the impacts of cancer diagnosis and treatment on quality of life, including physical and emotional well-being, treatment side effects, and the consequences of managing those side effects

Napo Pharmaceuticals Advocates For Collaborative Education Cancer Survey Quality Of Life SABCS 2023
PRESS RELEASE

published on 12/04/2023 at 14:30, 2 years 2 months ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea in Dogs
Jaguar Health, Inc. (NASDAQ:JAGX) has announced the renewal of conditional approval for Canalevia-CA1 (crofelemer delayed-release tablets) by the U.S. FDA for the treatment of chemotherapy-induced diarrhea (CID) in dogs. The renewal extends the validity until December 21, 2024, as the company plans a clinical field study to support full approval

Crofelemer FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea
PRESS RELEASE

published on 11/30/2023 at 14:30, 2 years 2 months ago

Jaguar Health to Present December 5 at the MedInvest Oncology Investor Conference
Jaguar Health, Inc. to present on Dec 5, 2023, at the MedInvest Oncology Investor Conference, discussing pivotal phase 3 OnTarget trial of crofelemer for prophylaxis of diarrhea in adult cancer patients receiving targeted therapy

Crofelemer Jaguar Health Oncology Investor Conference Phase 3 Clinical Trial Cancer Therapy
PRESS RELEASE

published on 11/21/2023 at 14:30, 2 years 3 months ago

Top Line Data for Jaguar Health’s Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Forthcoming
PRESS RELEASE

published on 11/14/2023 at 14:00, 2 years 3 months ago

Jaguar Health Reports Third Quarter 2023 Financial Results
PRESS RELEASE

published on 11/10/2023 at 22:15, 2 years 3 months ago

Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE

published on 11/09/2023 at 14:30, 2 years 3 months ago

Breast Cancer Related Results of Groundbreaking Napo Pharmaceuticals (a Jaguar Health Family Company) Supported Study on Quality of Life for Cancer Patients and Survivors Accepted for Presentation at the December 2023 San Antonio Breast Cancer Symposium
PRESS RELEASE

published on 11/08/2023 at 16:25, 2 years 3 months ago

Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq's Bid Price Rule
PRESS RELEASE

published on 11/08/2023 at 14:30, 2 years 3 months ago

Jaguar Health to Hold Investor Webcast Tuesday, November 14th at 8:30 AM Eastern Regarding Q3 2023 Financials & Corporate Updates
PRESS RELEASE

published on 11/07/2023 at 14:30, 2 years 3 months ago

REMINDER: Jaguar Health to Host Virtual Educational Webinar on Rare Intestinal Failure Diseases with Leading Gastroenterologists and Nutrition Experts November 8th from 1:00 PM to 2:30 PM EST

Published on 02/28/2026 at 10:00, 13 hours 16 minutes ago

Storm Exploration Issues Shares to Eabametoong First Nation
Published on 02/28/2026 at 03:00, 20 hours 16 minutes ago

Dynamite Blockchain Announces Change in Auditor
Published on 02/28/2026 at 02:00, 21 hours 16 minutes ago

Empress Reports 2025 Year End Financial Results
Published on 02/28/2026 at 00:10, 23 hours 6 minutes ago

Algo Grande Copper Closes Oversubscribed $6.52 Million Financing and Strengthens Board at AGM
Published on 02/28/2026 at 00:00, 23 hours 16 minutes ago

GECC Reports Director Election Results

View all ACCESSWIRE

Published on 02/28/2026 at 21:50, 1 hour 26 minutes ago

CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BSL RENDITION OF "YOU'LL NEVER WALK ALONE"
Published on 02/28/2026 at 21:20, 1 hour 56 minutes ago

Huawei's SuperPoD Portfolio Creates New Option for Global Computing at MWC Barcelona 2026
Published on 02/28/2026 at 21:00, 2 hours 16 minutes ago

CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BRITISH SIGN LANGUAGE RENDITION OF 'YOU'LL NEVER WALK ALONE'
Published on 02/28/2026 at 19:15, 4 hours 1 minute ago

Athletes from Sweden and the Netherlands Win Medals at the Olympic Winter Games Milano Cortina 2026 as Team TCL Ambassador Reaches the Podium
Published on 02/28/2026 at 16:55, 6 hours 21 minutes ago

CGTN: How China's path of democracy safeguards people's rights and interests

View all EQS

Published on 02/27/2026 at 23:00, 1 day ago

Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 1 day 5 hours ago

AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 17:45, 1 day 5 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025
Published on 02/27/2026 at 17:45, 1 day 5 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
Published on 02/27/2026 at 08:45, 1 day 14 hours ago

Air Liquide and Holcim sign an agreement to decarbonize cement production with a carbon capture project in Belgium

View all LES ECHOS COMFI WIRE

News